Carbicalcin

Carbicalcin may be available in the countries listed below.

Ingredient matches for Carbicalcin

Elcatonin

Elcatonin is reported as an ingredient of Carbicalcin in the following countries:

• Spain

International Drug Name Search

Synphase

Synphase may be available in the countries listed below.

UK matches:

• Synphase Tablets
• Synphase Tablets (SPC)

Ingredient matches for Synphase

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Synphase in the following countries:

• United Kingdom

Norethisterone

Norethisterone is reported as an ingredient of Synphase in the following countries:

• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Carvedilol PCH

Carvedilol PCH may be available in the countries listed below.

Ingredient matches for Carvedilol PCH

Carvedilol

Carvedilol is reported as an ingredient of Carvedilol PCH in the following countries:

• Netherlands

International Drug Name Search

Perazine

ATC (Anatomical Therapeutic Chemical Classification)

N05AB10

CAS registry number (Chemical Abstracts Service)

0000084-97-9

Chemical Formula

C20-H25-N3-S

Molecular Weight

339

Therapeutic Category

Neuroleptic

Chemical Name

10H-Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-

Foreign Name

• Perazin (German)

Generic Name

• P 725 (IS)

Brand Names

• Peragal
  Galena, Poland



• Perazin
  Hasco, Poland



• Perazin-neuraxpharm
  Neuraxpharm, Germany



• Pernazinum
  Labor, Poland



• Taxilan
  Lundbeck, Germany

International Drug Name Search

Glossary

IS	Inofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Articadent

In the US, Articadent (articaine/epinephrine systemic) is a member of the drug class local injectable anesthetics and is used to treat Anesthesia and Local Anesthesia.

US matches:

• Articadent

Ingredient matches for Articadent

Articaine

Articaine hydrochloride (a derivative of Articaine) is reported as an ingredient of Articadent in the following countries:

• France

Epinephrine

Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Articadent in the following countries:

• France

International Drug Name Search

Tamsulosina Normon

Tamsulosina Normon may be available in the countries listed below.

Ingredient matches for Tamsulosina Normon

Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosina Normon in the following countries:

• Spain

International Drug Name Search

Veraptin

Veraptin may be available in the countries listed below.

Ingredient matches for Veraptin

Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Veraptin in the following countries:

• Italy

International Drug Name Search

Amicacina Braun

Amicacina Braun may be available in the countries listed below.

Ingredient matches for Amicacina Braun

Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amicacina Braun in the following countries:

• Spain

International Drug Name Search

Lipitor

Lipitor is a brand name of atorvastatin, approved by the FDA in the following formulation(s):

LIPITOR (atorvastatin calcium - tablet; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: December 17, 1996
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 20MG BASE ^[AB], EQ 40MG BASE ^[AB]


• 
  Manufacturer: PFIZER
  
  Approval date: April 7, 2000
  
  Strength(s): EQ 80MG BASE ^[RLD][AB]

Has a generic version of Lipitor been approved?

A generic version of Lipitor has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Lipitor and have been approved by the FDA:

atorvastatin calcium tablet; oral

• 
  Manufacturer: RANBAXY LABS LTD
  
  Approval date: November 30, 2011
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 20MG BASE ^[AB], EQ 40MG BASE ^[AB], EQ 80MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lipitor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Stable oral CI-981 formulation and process of preparing same
  Patent 5,686,104
  Issued: November 11, 1997
  Inventor(s): Mills; Nancy & Muhammad; Nouman A. & Weiss; Jay & Nesbitt; Russell U.
  Assignee(s): Warner-Lambert Company
  An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
  
  Patent expiration dates:
  
  
  • November 11, 2014
    
    ✓ 
    Patent use: METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA AND METHOD FOR TREATING HYPERLIPIDEMIA
    ✓ 
    Drug product
  
  
  
  • May 11, 2015
    
    ✓ 
    Patent use: METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA AND METHOD FOR TREATING HYPERLIPIDEMIA
    ✓ 
    Pediatric exclusivity
  
  



• 
  Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
  Patent 5,969,156
  Issued: October 19, 1999
  Inventor(s): Briggs; Christopher A. & Jennings; Rex A. & Wade; Robert & Harasawa; Kikuko & Ichikawa; Shigeru & Minohara; Kazuo & Nakagawa; Shinsuke
  Assignee(s): Warner-Lambert Company
  Crystalline forms of atorvastatin and hydrates thereof are useful hypolipidemic and hypocholesterolemic agents.
  
  Patent expiration dates:
  
  
  • July 8, 2016
    
    ✓ 
    Drug substance
  
  
  
  • January 8, 2017
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Stable oral CI-981 formulation and process for preparing same
  Patent 6,126,971
  Issued: October 3, 2000
  Inventor(s): Mills; Nancy & Muhammad; Nouman A. & Weiss; Jay & Nesbitt; Russell U.
  Assignee(s): Warner-Lambert Company
  An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
  
  Patent expiration dates:
  
  
  • January 19, 2013
    
    ✓ 
    Drug product
  
  
  
  • July 19, 2013
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Lipitor Consumer Information (Drugs.com)
• Lipitor Consumer Information (Wolters Kluwer)
• Lipitor Consumer Information (Cerner Multum)
• Lipitor Advanced Consumer Information (Micromedex)
• Lipitor AHFS DI Monographs (ASHP)
• Atorvastatin Consumer Information (Drugs.com)
• Atorvastatin Consumer Information (Wolters Kluwer)
• Atorvastatin Consumer Information (Cerner Multum)
• Atorvastatin Advanced Consumer Information (Micromedex)
• Atorvastatin Calcium AHFS DI Monographs (ASHP)

Wizol

Wizol may be available in the countries listed below.

Ingredient matches for Wizol

Ketoconazole

Ketoconazole is reported as an ingredient of Wizol in the following countries:

• Indonesia

International Drug Name Search